| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 378,865 | 372,605 | 355,396 | 398,082 | | Cost of Revenue | 298,347 | 292,761 | 283,685 | 318,236 | | | Gross Profit | 80,518 | 79,844 | 71,711 | 79,846 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,069 | 48,563 | 41,796 | 31,267 | | Non Recurring |
-
|
-
|
-
| 13,899 | | Others | 3,375 | 3,321 | 3,258 | 3,182 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 45,074 | 27,960 | 26,657 | 31,498 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,140 | 5,035 | (1,948) | (16,707) | | Earnings Before Interest And Taxes | 48,214 | 32,995 | 24,709 | 14,791 | | Interest Expense | 4,807 | 4,839 | 4,498 | 5,829 | | Income Before Tax | 43,407 | 28,156 | 20,211 | 8,962 | | Income Tax Expense | 15,343 | 9,731 | 7,479 | 1,835 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 28,064 | 18,425 | 12,732 | 7,127 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (336) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,064 | 18,425 | 12,732 | 6,791 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,064 | $18,425 | $12,732 | $6,791 |
|
0.22% Nasdaq 
Income Statement
